These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34445291)

  • 1. Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells.
    Salzillo A; Ragone A; Spina A; Naviglio S; Sapio L
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells.
    Sapio L; Salzillo A; Illiano M; Ragone A; Spina A; Chiosi E; Pacifico S; Catauro M; Naviglio S
    J Cell Physiol; 2020 Apr; 235(4):3741-3752. PubMed ID: 31602671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
    Chiosi E; Spina A; Sorrentino A; Romano M; Sorvillo L; Senatore G; D'Auria R; Abbruzzese A; Caraglia M; Naviglio S; Illiano G
    J Interferon Cytokine Res; 2007 Jul; 27(7):589-97. PubMed ID: 17651020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.
    Spina A; Sorvillo L; Chiosi E; Esposito A; Di Maiolo F; Sapio L; Caraglia M; Naviglio S
    Oncol Rep; 2013 May; 29(5):1689-96. PubMed ID: 23446517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kit
    Carresi C; Musolino V; Gliozzi M; Maiuolo J; Mollace R; Nucera S; Maretta A; Sergi D; Muscoli S; Gratteri S; Palma E; Bosco F; Giancotta C; Muscoli C; Marino F; Aquila I; Torella D; Romeo F; Mollace V
    J Mol Cell Cardiol; 2018 Jun; 119():10-18. PubMed ID: 29654879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity.
    Rocca C; Scavello F; Colombo B; Gasparri AM; Dallatomasina A; Granieri MC; Amelio D; Pasqua T; Cerra MC; Tota B; Corti A; Angelone T
    FASEB J; 2019 Jun; 33(6):7734-7747. PubMed ID: 30973759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanillin Prevents Doxorubicin-Induced Apoptosis and Oxidative Stress in Rat H9c2 Cardiomyocytes.
    Sirangelo I; Sapio L; Ragone A; Naviglio S; Iannuzzi C; Barone D; Giordano A; Borriello M
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32752227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
    Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
    Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorogenic acid: A potent molecule that protects cardiomyocytes from TNF-α-induced injury via inhibiting NF-κB and JNK signals.
    Tian L; Su CP; Wang Q; Wu FJ; Bai R; Zhang HM; Liu JY; Lu WJ; Wang W; Lan F; Guo SZ
    J Cell Mol Med; 2019 Jul; 23(7):4666-4678. PubMed ID: 31033175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.
    Murahari S; Jalkanen AL; Kulp SK; Chen CS; Modiano JF; London CA; Kisseberth WC
    BMC Cancer; 2017 Jan; 17(1):67. PubMed ID: 28109246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.
    Paiva-Oliveira DI; Martins-Neves SR; Abrunhosa AJ; Fontes-Ribeiro C; Gomes CMF
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):49-63. PubMed ID: 29086064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting inflammatory kinase as an adjuvant treatment for osteosarcomas.
    Noh K; Kim KO; Patel NR; Staples JR; Minematsu H; Nair K; Lee FY
    J Bone Joint Surg Am; 2011 Apr; 93(8):723-32. PubMed ID: 21508279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment of human osteosarcoma cells with N-methylformamide enhances P-glycoprotein expression and resistance to doxorubicin.
    Scotlandi K; Serra M; Manara MC; Lollini PL; Maurici D; Del Bufalo D; Baldini N
    Int J Cancer; 1994 Jul; 58(1):95-101. PubMed ID: 7912235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma.
    Coutinho L; Oliveira H; Pacheco AR; Almeida L; Pimentel F; Santos C; Ferreira de Oliveira JM
    DNA Repair (Amst); 2017 Feb; 50():36-42. PubMed ID: 28063664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
    Dieudonné FX; Marion A; Marie PJ; Modrowski D
    J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorogenic acid inhibits osteosarcoma carcinogenesis via suppressing the STAT3/Snail pathway.
    Zhang F; Yin G; Han X; Jiang X; Bao Z
    J Cell Biochem; 2019 Jun; 120(6):10342-10350. PubMed ID: 30582213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo.
    Zhai L; Sun N; Han Z; Jin HC; Zhang B
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):274-80. PubMed ID: 26505795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
    Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
    Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
    Chegaev K; Rolando B; Cortese D; Gazzano E; Buondonno I; Lazzarato L; Fanelli M; Hattinger CM; Serra M; Riganti C; Fruttero R; Ghigo D; Gasco A
    J Med Chem; 2016 May; 59(10):4881-9. PubMed ID: 27120394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.